Journal of the American College of Nutrition · 1984 · 18 citations · 13 references
MedicinePharmacokineticsPharmacologyPharmacodynamicsPharmacokinetic-pharmacodynamic ModelingPopulation PharmacokineticsVitamin D DisordersVitamin D MetabolismConcentration-dose Ratio AnalysisPhenytoin TherapyVitamin D PharmacokineticsVitamin D Physiology
The circulating 25-hydroxyvitamin D [25(OH)D] and 1,25-dihydroxyvitamin D [1,25-(OH)2D] concentrations were studied in a patient receiving increasing doses of phenytoin. The plasma 1,25(OH)2D concentrations were independent of the dose of phenytoin administered, as well as of the drug plasma concentrations. The plasma 25(OH)D concentrations were, on the other hand, increased by low phenytoin concentration but rapidly declined when the dose of phenytoin was increased and/or as the length of time of exposure to the drug increased. A linear relationship (R = 0.9651, P less than 0.05) was found between the plasma 25(OH)D concentrations and the dose/plasma phenytoin concentration ratio, suggesting that chronic phenytoin administration may have a dose-related effect on the circulating 25(OH)D concentrations.
13
Enterohepatic physiology of 1,25-dihydroxyvitamin D3.
Rajiv Kumar, Sreeramulu Nagubandi, Vernon R. Mattox et al. · Journal of Clinical Investigation · 1980 · 96 citations · Full text